Fever, cutaneous lesions and adenopathies;Fiebre, lesiones cutaneas y adenopatias

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 17, Issue 3, 1999, Pages 143-144

  Mena, Francisco Javier ^a   Pérez, José Luis ^a   Martín Luquero, Miguel ^a   Bachiller, Pablo ^a   Labayru, Cristina ^a   Herreros, Vicente ^a  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; NORFLOXACIN;

ADULT; ARTICLE; CLINICAL FEATURE; FEVER; HUMAN; LYMPHADENOPATHY; SKIN DEFECT; SYMPTOM; TULAREMIA; CASE REPORT; MALE; MIDDLE AGED; PATHOLOGY; SKIN;

FEVER; HUMANS; MALE; MIDDLE AGED; SKIN; TULAREMIA;

EID: 2442752593     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. a ed.). Nueva York: Churchill Livingstone Inc., 1995; 2.308-2.317.
2. Arenas R, Tularemia. Estudio de un caso ulceroglandular. Rev Semin Cátedra Patol Med A Barc 1981; 14: 397-400.
3. th International Congress for Infectious Diseases. Praga; abril, 1994.
4. Instituto de Salud Carlos III. Ministerio de Sanidad y Consumo. Brote de tularemia en Castilla y León. Bol Epidemiol Semanal 1997; 5: 249-252.
5. Sanders CV, Hahn R. Analysis of 106 cases of tularemia. J Louisiana State Med Soc 1968; 120: 391-393.
6. Case definition for infectious conditions under public health surveillance. U.S. Department of Health and Human Services. Public Health Service Center for Disease Control and Prevention (CDC). MMWR 1997; 48: 53-54.
7. Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect. Dis 1994; 19: 42-47.
8. Penn RL, Kinasewitz GT. Factors associated with a poor outcome in tularemia. Arch Intern Med 1987; 147: 265-268.